Is Admelog 15 units TID + Tuojeo 50 units QD adequate for a 220‑lb woman with an A1C of 11.1%?

No—this regimen is profoundly inadequate and represents dangerous under‑dosing for severe hyperglycemia. The total daily insulin dose of only 95 units (45 U prandial + 50 U basal) is far below the weight‑based requirement for an A1C of 11.1%, and the current dosing structure fails to address both fasting and post‑prandial hyperglycemia. Immediate aggressive intensification with systematic titration is required to prevent long‑term complications.

Critical Problems with the Current Regimen

1. Severe Under‑Dosing for the Degree of Hyperglycemia

An A1C of 11.1% indicates severe uncontrolled diabetes requiring a total daily insulin dose of 0.3–0.5 units/kg/day (approximately 30–50 units/day for a 100‑kg [220‑lb] patient), which translates to 30–50 units total for initial therapy—yet this patient receives only 95 units, which is still insufficient given the severity 1.
For patients with A1C ≥9%, guidelines explicitly recommend higher starting doses of 0.3–0.5 units/kg/day as total daily insulin, split between basal and prandial components 1, 2.
The current Tuojeo 50 units represents only ≈0.5 units/kg/day, which is at the critical threshold where further basal escalation should stop and prandial insulin should be intensified instead 1, 3.

2. Inadequate Prandial Coverage

Admelog 15 units TID (45 units total prandial) is insufficient for an A1C of 11.1%, which reflects both inadequate basal coverage and uncontrolled post‑prandial hyperglycemia 1.
For severe hyperglycemia, prandial insulin should start at ≈10–12 units per meal (30–36 units total) and be titrated aggressively by 2 units every 3 days based on 2‑hour post‑prandial glucose readings 1.
The current 15 units per meal is a reasonable starting point but has clearly not been titrated adequately, as evidenced by the A1C of 11.1% 1.

3. Signs of "Over‑Basalization" Despite Inadequate Control

Tuojeo 50 units (≈0.5 units/kg/day) is at the critical threshold where further basal escalation should cease and prandial insulin should be intensified 1, 3.
Clinical signals of over‑basalization include:
- Basal dose >0.5 units/kg/day without achieving A1C goals 3.
- A1C remaining above target despite controlled fasting glucose (if fasting glucose is 80–130 mg/dL but A1C is 11.1%, this indicates inadequate prandial coverage) 3.
- High glucose variability throughout the day 3.
Continuing to escalate Tuojeo beyond 0.5–1.0 units/kg/day without addressing post‑prandial hyperglycemia leads to suboptimal control and increased hypoglycemia risk 1, 3.

Immediate Medication Adjustments Required

1. Aggressive Prandial Insulin Titration

Increase Admelog to 20–25 units before each meal (60–75 units total prandial) immediately, then titrate by 2 units every 3 days based on 2‑hour post‑prandial glucose readings 1.
Target post‑prandial glucose <180 mg/dL 1.
Administer Admelog 0–15 minutes before meals for optimal post‑prandial control 1.

2. Basal Insulin Adjustment

Maintain Tuojeo at 50 units (do not increase further) and focus on prandial intensification 1, 3.
If fasting glucose remains ≥180 mg/dL, increase Tuojeo by 4 units every 3 days until fasting glucose reaches 80–130 mg/dL, but stop escalation once the dose approaches 0.5–1.0 units/kg/day (50–100 units) 1.
If fasting glucose is 140–179 mg/dL, increase Tuojeo by 2 units every 3 days 1.

3. Correction Insulin Protocol

Add 2 units of Admelog for pre‑meal glucose >250 mg/dL and 4 units for glucose >350 mg/dL, in addition to scheduled prandial doses 1.

Foundation Therapy: Metformin Optimization

Ensure metformin is continued at the maximum tolerated dose (up to 2000–2550 mg daily) unless contraindicated 1.
Metformin reduces total insulin requirements by 20–30% and provides superior glycemic control when combined with insulin 1.
Never discontinue metformin when intensifying insulin therapy unless specific contraindications exist (e.g., renal impairment, acute illness) 1.

Monitoring Requirements During Titration

Daily fasting glucose to guide Tuojeo adjustments 1.
Pre‑meal glucose before each meal to calculate correction doses 1.
2‑hour post‑prandial glucose after each meal to assess Admelog adequacy 1.
Bedtime glucose to evaluate overall daily pattern 1.
Reassess insulin doses every 3 days during active titration 1.
A1C every 3 months until stable control is achieved 1.

Expected Clinical Outcomes with Proper Intensification

With appropriately weight‑based basal‑bolus therapy, ≈68% of patients achieve mean glucose <140 mg/dL, compared with ≈38% with inadequate dosing 1.
A1C reduction of 3–4% (from 11.1% to ≈7–8%) is achievable within 3–6 months with intensive insulin titration combined with metformin 1.
Properly implemented basal‑bolus regimens do not increase hypoglycemia incidence compared with inadequate sliding‑scale approaches 1.

Critical Pitfalls to Avoid

Do not delay prandial insulin intensification when A1C is 11.1%; this level of hyperglycemia mandates both basal and mealtime coverage 1.
Do not continue escalating Tuojeo beyond 0.5–1.0 units/kg/day without addressing post‑prandial hyperglycemia; this leads to over‑basalization and increased hypoglycemia risk 1, 3.
Never discontinue metformin when intensifying insulin unless contraindicated, as this leads to higher insulin requirements and more weight gain 1.
Do not rely solely on correction (sliding‑scale) insulin without adjusting scheduled basal and prandial doses; this reactive strategy is condemned by major diabetes guidelines 1.

Hypoglycemia Management

Treat glucose <70 mg/dL promptly with 15 g of fast‑acting carbohydrate, recheck in 15 minutes, and repeat if needed 1.
If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% immediately 1.
Provide comprehensive patient education on hypoglycemia recognition, treatment, proper injection technique, and sick‑day management 1.

Alternative to Further Prandial Insulin: GLP‑1 Receptor Agonist

If Tuojeo exceeds 0.5 units/kg/day without achieving targets, consider adding a GLP‑1 receptor agonist (e.g., semaglutide) instead of further prandial insulin intensification 1, 4.
The basal‑insulin + GLP‑1 RA combination provides comparable post‑prandial control with less hypoglycemia and weight loss rather than weight gain 1, 4.
However, for severe hyperglycemia (A1C ≈11%), immediate basal‑bolus insulin intensification is preferred to achieve rapid control 1.

Summary Algorithm

Increase Admelog to 20–25 units before each meal (60–75 units total prandial) immediately 1.
Maintain Tuojeo at 50 units (do not increase further unless fasting glucose remains ≥180 mg/dL) 1, 3.
Titrate Admelog by 2 units every 3 days based on 2‑hour post‑prandial glucose, targeting <180 mg/dL 1.
Ensure metformin is continued at maximum tolerated dose (up to 2000–2550 mg daily) 1.
Monitor daily fasting glucose, pre‑meal glucose, and 2‑hour post‑prandial glucose 1.
Reassess every 3 days during active titration and every 3 months with A1C until stable control is achieved 1.

Is a regimen of insulin lispro 15 units three times daily plus insulin glargine (Toujeo) 50 units once daily appropriate for a 220‑lb woman with an A1C of 11.1%?

Help us tailor your experience